Antonello Bonci

Edit links
Source: Wikipedia, the free encyclopedia.
Antonello Bonci
Alma materUniversità Cattolica del Sacro Cuore (MD)
Scientific career
FieldsNeuropsychopharmacology
InstitutionsUniversity of California, San Francisco
National Institute on Drug Abuse

Antonello Bonci is an Italian-American

neurologist and a neuropsychopharmacologist specialized in the long-term effects of drug exposure on the brain. In August 2019, he became president of Global Institutes on Addictions Miami. Bonci was previously the scientific director of the National Institute on Drug Abuse and a professor at the University of California, San Francisco
.

Education

In 1985, Bonci went to Medical School at the

cum laude in 1991. In that same year, he started a Residency in Neurology at the University of Rome Tor Vergata where he graduated cum laude in 1995.[1]

Career

Bonci became assistant professor in Residence at the

UCSF), the Howard J. Weinberg Endowed Chair in Addiction Research, and the Associate Director for Extramural Affairs at the Ernest Gallo Clinic and Research Center. In 2010, he was appointed as the Scientific Director of National Institute on Drug Abuse (NIDA).[2] Bonci resigned from his position in August 2019 after a sexual misconduct probe was opened against him for allegedly "sexual targetting" a trainee as well as directing resources to another trainee with whom he had an intimate relationship.[3][4][5]

Bonci is currently the President and Chief Scientific Officer at GIA Miami and Vita Recovery.

Research

Bonci is known for his studies on the long-term effects of

drug addiction, as a process where maladaptive learning plays a role.[9] Subsequent studies have combined electrophysiological, optogenetic, molecular, and behavioral techniques to determine the long-term effects that are produced by chronic exposure to stress, cocaine or ethanol, with the goal of creating novel therapeutic avenues to decrease the devastating effects of these conditions.[10][11] In 2013, a study led by Billy T. Chen,[12] provided rationale for the use of non-invasive brain stimulation, such as repeated Transcranial Magnetic Stimulation, in patients with cocaine use disorders. Clinical studies have indeed shown the potential of such technology in the treatment of cocaine use disorders.[13][14][15][16]; In Europe, publications by Dr. Bonci and collaborators have been used by the TMS company Mag Venture to obtain the European CE approval for treatment of addiction.[17]

Publications (non-exhaustive list)

Awards and honors

October, 2004 - Jacob P. Waletzky Memorial Award [18]

December, 2009 - Daniel H. Efron Award at the American College of Neuropsychopharmacology[19]

February 6, 2014 - Officer of the Order of the Star of Italy.

November, 2015 - PrimiDieci USA [20]

July, 2016 - Federation of European Neuroscience Societies and European Journal of Neuroscience Award.

October, 2016 - Member of the National Academy of Medicine[21]

References

  1. ^ "Antonello Bonci, M.D. Scientific Director - Principal Investigators - The Intramural Research Program of the National Institute on Drug Abuse". 2014-02-01. Archived from the original on 2014-02-01. Retrieved 2020-09-10.
  2. ^ "Leading Addiction Researcher Antonello Bonci joins NIDA to lead Intramural Research Program". 26 August 2015.Public Domain This article incorporates text from this source, which is in the public domain.
  3. ^ Wadman, Meredith (5 November 2019). "Science chief at NIH drug abuse institute resigned after sexual misconduct probe". Science. Retrieved 14 February 2023.
  4. ^ "ANTONELLO BONCI". Academic Sexual Misconduct Database. Retrieved 14 February 2023.
  5. ^ Neote, Sarina (9 October 2020). "Survey: 1 in 5 NIH workers were sexually harassed in past year". ASBMB Today. Retrieved 14 February 2023.
  6. ^ "Laser Light Zaps Away Cocaine Addiction".
  7. ^ "Zap a cocaine addiction with lasers?". CBS News.
  8. S2CID 4311436
    .
  9. PMID 20624588
    .
  10. PMID 21712648
    .
  11. PMID 32161361
    .
  12. S2CID 4397137
    .
  13. PMID 26655188
    .
  14. PMID 32180745
    .
  15. S2CID 47010124
    .
  16. PMID 31271802
    .
  17. ^ "PRESS RELEASE: Addiction, OCD & Comorbid Anxiety".
  18. ^ "Bulletin Board". May 2005.
  19. ^ "Daniel H. Efron Research Previous Award Winners". ACNP. Retrieved 2022-08-24.
  20. ^ "PrimiDieci Society I Global Leaders Network I Ten Best".
  21. ^ "National Academy of Medicine Elects 80 New Members". 17 October 2016.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Antonello_Bonci&oldid=1212857852"